Esterline price target raised to $80 from $73 at Imperial Capital

Imperial Capital raised its price target for Esterline ahead of the company's Q1 results and keeps an Outperform rating on the stock. The firm expects Esterline to report Q1 results consistent with estimates, and does not expect the company to raise its 2013 guidance.

View Comments (0)